The question is asked in good faith and it deserves better than it usually gets. Search it and you find two kinds of page. One sells drops, or a diet, or a course. The other is two dismissive lines on a clinic site that never explains why.
There is a real answer, it is more interesting than either, and part of it comes from a trial that specifically tested the thing most people are about to buy.
The misconception that makes reversal sound possible
Most people picture a cataract as a film, a skin, something growing over the surface of the eye. On that picture, dissolving it is an obvious idea, and every product in this category quietly relies on you holding it.
It is wrong. The lens sits behind the iris, inside the eye, and it is transparent for a reason most people never hear: its proteins are packed in an unusually precise arrangement that lets light through without scattering. That is the whole trick, and it is structural.
A cataract is that arrangement degrading. The proteins clump, the packing loses its regularity, and light begins to scatter instead of passing. The NEI describes the result as a cloudy area in the lens of your eye.
There is nothing on the outside of the eye to clear away. The clouding is the lens, and you cannot un-boil an egg with eye drops.
This is also why the symptoms are what they are: cloudy or blurry vision, colours looking faded, poor vision at night, and lamps or headlights seeming too bright. Scattered light does all four.
The trial that tested the supplements, and what it found
Here is the part almost nobody knows. The Age-Related Eye Disease Study, the trial that produced the entire AREDS supplement category, did not only study macular degeneration. It ran a cataract arm at the same time, in the same cohort, and published it as report no. 9.
4,629 participants aged 55 to 80 with at least one natural lens. Vitamin C 500 mg, vitamin E 400 IU, beta-carotene 15 mg, daily. Lens photographs taken at baseline and every year, graded at a reading centre against a formal cataract scale. Average follow-up 6.3 years.
| Outcome measured | Result |
|---|---|
| Development or progression of lens opacities | Odds ratio 0.97, p=0.55 |
| Nuclear opacity | no significant effect |
| Cortical opacity | no significant effect |
| Posterior subcapsular opacity | no significant effect |
| Cataract surgery | no significant effect |
| Moderate visual acuity loss | no significant difference |
Arch Ophthalmol 2001;119(10):1439-52. An odds ratio of 0.97 with p=0.55 means the treated and untreated groups were indistinguishable. The authors' own conclusion: no apparent effect on the 7-year risk of development or progression of age-related lens opacities or visual acuity loss.
Nothing. Not a small effect, not a trend, not something that might have reached significance with more people. Six years of daily high-dose antioxidants, photographed and graded annually, and the two groups looked the same.
And now the part that should change how you shop
The same trial. The same participants. The same tablets. Reported in the same journal, in the same month, in 2001.
One formulation, two diseases, two answers
Macular degeneration (report no. 8)
- Five-year progression 28% on placebo, 20% on the formulation
- Odds ratio 0.72
- The basis of the entire AREDS category
Cataract (report no. 9)
- No difference in lens opacity progression
- Odds ratio 0.97, p=0.55
- Almost never mentioned by anyone selling the formulation
Sit with that for a moment. The same pills, in the same eyes, over the same six years, shifted one age-related eye disease and did absolutely nothing to another one a few millimetres away.
Which means the phrase eye vitamin is empty. There is no nutrient that is good for eyes in general, because the eye is not one thing and its diseases have nothing mechanically in common. There are formulations that were tested against a named condition in a named group, and everything else is marketing. That is the same lesson as what AREDS2 does and does not do, arriving from the opposite direction.
What about the drops?
Eye drops marketed to dissolve or reverse cataracts appear and disappear regularly, usually sold direct to consumers and usually from outside the country the buyer lives in.
The position of the national eye institute is not ambiguous and does not carve out an exception: surgery is the only way to get rid of a cataract. There is no approved drop for cataract, in the United States or the European Union, and a product being purchasable is not the same as a product having been shown to work.
The mechanical argument is worth holding on to as well. A drop lands on the surface of the eye. The cataract is in the lens, behind the iris, in a compartment the drop has to cross several barriers to reach at any useful concentration. That is not an argument that it is impossible. It is an argument for wanting to see the trial before spending anything.
What does change your risk
Nothing here reverses a cataract you already have. All of it is about the rate at which the lens ages, and it is the same unglamorous list the NEI publishes.
- Not smoking. The NEI lists smoking among the things that raise cataract risk, and it is the largest modifiable item on this page by a wide margin.
- UV protection. Cumulative ultraviolet exposure is linked to cortical cataract. Sunglasses rated UV400, worn year-round, and the rating matters more than the price.
- Blood sugar. Diabetes raises the risk, and it is on the NEI's own list of conditions that do.
- Alcohol, within reason. Drinking too much is on the same list. This is not a moral point, it is an entry in a risk table.
All four are in the wider set of habits that hold up over decades, and none of them is exciting, which is precisely why they have to compete against products that are.
The thing everyone is trying to avoid is the thing that works
Most of the demand for a natural cure is really a wish not to have eye surgery, which is an entirely reasonable thing to feel.
It is worth knowing what is actually being avoided. The surgeon removes the clouded lens and puts an artificial one in its place. The NEI's own summary is that the operation is very safe and that nine out of ten people who have it see better afterwards.
Nine out of ten. There is nothing else in this article, or in the aisle it describes, with a number remotely like that attached to it.
When to have it done is a conversation with an ophthalmologist rather than a threshold you can read off a page, and it usually turns on whether the cloudiness has started to interfere with the things you actually do. Driving at night is often the one that decides it.